William Blackwell
8Patents
1h-index
15Co-inventors
40Inventor score
Filing activity: May 15, 2017 → Feb 28, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10501517B2 | Glucagon-receptor selective polypeptides and methods of use thereof | Human Necessities | 2 | Active |
| US11214607B2 | Glucagon-receptor selective polypeptides and methods of use thereof | Human Necessities | 1 | Active |
| US11739134B2 | Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use | Human Necessities | 1 | Active |
| US12018059B2 | Human amylin analog polypeptides and methods of use | Human Necessities | 0 | Active |
| US11840559B2 | Glucagon-receptor selective polypeptides and methods of use thereof | Human Necessities | 0 | Active |
| US12084485B2 | Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of use | Human Necessities | 0 | Active |
| US12122816B2 | Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use | Human Necessities | 0 | Active |
| US12427212B2 | Nectin-4 binding miniproteins, conjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.